Delivery Order SPE2DB24D3013-SPE2DB25FFMET
Award Date
6/4/25
Potential Completion Date
6/5/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $2,376.00 and is a firm fixed price, non-set-aside contract with a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a medication, with a ceiling value of $17,739.20 and a performance period ending on May 20, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $8,513.01 and a performance period ending on May 1, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of GEMTESA 75 MG TABLET 30S, a medication, with a ceiling value of $1,798.05 and a period of performance through May 6, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract is a firm fixed price delivery order with a ceiling value of $26,794.80 and a completion date of June 5, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $31,102.17 and a period of performance through February 20, 2024. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEMTESA 75 MG TABLET 90S, with a ceiling value of $1,143.62 and a period of performance ending on May 16, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $9,547.86 and is a firm fixed-price delivery order type contract, without any set-aside designation. The contract has an ultimate completion date of April 23, 2025. AmerisourceBergen Drug Corporation holds a significant...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The contract has a ceiling value of $30,348.20 and a period of performance through September 7, 2023. The contract is not set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $43,318.33 and a completion date of May 16, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...